Unknown

Dataset Information

0

Constitutional DNA Polymorphisms Associated with the Plasma Imatinib Concentration in Chronic Myeloid Leukemia Patients

ABSTRACT:

SUBMITTER: Bruzzoni-Giovanelli H 

PROVIDER: S-EPMC11207966 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Effect of imatinib on plasma glucose concentration in subjects with chronic myeloid leukemia and gastrointestinal stromal tumor.
| S-EPMC6215634 | biostudies-literature
Unknown Factors Influencing the Steady-State Plasma Concentration of Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors and Chronic Myeloid Leukemia.
| S-EPMC7768902 | biostudies-literature
Unknown Single nucleotide polymorphisms in apoptosis pathway are associated with response to imatinib therapy in chronic myeloid leukemia.
| S-EPMC4806489 | biostudies-literature
Unknown The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients.
| S-EPMC6209720 | biostudies-literature
Unknown Influence of CYP2C8*3 and ABCG2 C421A genetic polymorphisms on trough concentration and molecular response of imatinib in Egyptian patients with chronic myeloid leukemia.
| S-EPMC11666798 | biostudies-literature
Unknown Downregulation of Plasma miR-215 in Chronic Myeloid Leukemia Patients with Successful Discontinuation of Imatinib.
| S-EPMC4849026 | biostudies-literature
Unknown Aberrant DNA methylation at HOXA4 and HOXA5 genes are associated with resistance to imatinib mesylate among chronic myeloid leukemia patients.
| S-EPMC7941502 | biostudies-literature
Unknown Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.
| S-EPMC5901965 | biostudies-literature
Unknown [Effect of MDR1 and CYP3A5 gene polymorphisms on outcomes of patients receiving imatinib treatment for chronic myeloid leukemia].
| S-EPMC6765618 | biostudies-literature
Unknown Rapid conversion of chronic myeloid leukemia to chronic myelomonocytic leukemia in a patient on imatinib therapy.
| S-EPMC5093026 | biostudies-literature